GAMCO Investors’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

GAMCO Investors’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,050	Closed	-$376K	–	884
2023 Q4	$376K	Buy	+6,050	New	+$150K	﹤0.01%	723

GAMCO Investors's RYZB Position: Q1 2024 in Review

GAMCO Investors sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 6,050 shares — an estimated $376K sold.

GAMCO Investors first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $376K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

GAMCO Investors reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
GAMCO Investors sold 6,050 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $376K.
GAMCO Investors first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
GAMCO Investors's RayzeBio, Inc. Common Stock position peaked at $376K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on GAMCO Investors's 13F filing for Q1 2024, filed 14 May 2024.